The Chinese medtech industry is undergoing a period of rapid and significant transformation.
Building on insights from our recent blog, 2025 outlook for medtech in China, this webinar will take a deeper look at the regulatory, policy, and commercial developments shaping the future of this critical market.
Join us to explore the shifting landscape, uncover emerging opportunities, and understand the success factors needed to thrive in this fast-evolving environment.
This webinar will cover:
China's regulatory and policy landscape: Explore China's new Medical Device Management Law, the effects of payment reforms such as DRG and DIP, with a deep-dive into Volume-Based Procurement (VBP) and price transparency implications and the impact of the latest tariff developments.
China's market access opportunities: Understand the mechanisms for accelerated approval, early access programs, and the growing role of Real-World Evidence (RWE) and Health Technology Assessment (HTA) in securing market entry and reimbursement.
Reimbursement and funding strategies: Learn about reimbursement pathways at the national and regional levels, opportunities with commercial health insurance, and innovative funding models that are shaping the future of medtech in China.
This webinar is free of charge. Register now to gain a comprehensive understanding of the trends redefining the medtech industry in China and position your organization for long-term success in one of the world’s most important healthcare markets.
Event details:
Date: June 26, 2025
Time: 5:00 - 6:00 p.m. CEST | 11:00 a.m. - 12:00 p.m. EDT | 8:00 - 9:00 a.m. PDT
